“What I recommend for most of my patients who have significant COPD is to enroll in a pulmonary rehabilitation program .” ...

Any patient presenting with symptomatic COPD or another pulmonary disease ... Training of upper extremity muscle groups. Many exercise programs focus on lower-extremity training.

Group B also received treadmills and followed a home-based exercise program on paper ... This study's findings offer a promising approach to managing COPD, suggesting that empowering patients to ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with type 2 ...

The following is a summary of "Determining the Impact of COVID-19 Infection on Patients Hospitalized With COPD Exacerbations: ...

It is clinically relevant among patients with COPD and may lead to dyspnea, impaired exercise tolerance ... of the burden of COPD and to develop programs for early detection, prevention, and ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...